eras-601,cetuximab
eli lilly,erasca
['cetuximab', 'eras-601', 'solid tumor']
$eras erasca delivers promising phase 1b results for eras-601 plus cetuximab in advanced solid tumors at aacr annual meeting. more info: #drugresearch #cancertherapy #aacr2023 $xbi $ibb $xph $pph
Latest BioPharma/Biotech News. Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  https://t.co/lvTtwarrGT